NCLEX RN NEWEST 2023, 2024 AND 2025 (3 LATEST VERSIONS) ACTUAL TEST BANK WITH 2500 ACTUAL EXAM QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES/BRAND NEW!!2024

NCLEX RN NEWEST 2023, 2024 AND 2025 (3 LATEST VERSIONS) ACTUAL TEST BANK WITH 2500 ACTUAL EXAM QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES/BRAND NEW!!2024 A 23-year-old woman is admitted to the infusion clinic after a Multiple Sclerosis Exacerbation. The physician orders methylprednisolone infusions (Solu-Medrol). The nurse would expect which of the following outcomes after administration of this medication? 1. A decrease in muscle spasticity and involuntary movements 2. A slowed progression of Multiple Sclerosis related plaques 3. A decrease in the length of the exacerbation 4. A stabilization of mood and sleep – ans1. A decrease in muscle spasticity and involuntary movements RATIONALE: Incorrect - While muscle spasticity and involuntary movements can be symptoms of MS, a corticosteroid infusion is not meant to directly treat these symptoms. 2. A slowed progression of Multiple Sclerosis related plaques Incorrect - Special drugs like Interferon Beta, Natalizumab, or Glatiramir acetate are used as first-line treatments to slow the progression of MS. While corticosteroids can be used in conjunction with these drugs on a long-term basis, they would not be infused. They would be taken orally. 3. A decrease in the length of the exacerbation Correct - A methylprednisolone infusion is the first line of treatment during an acute exacerbation and is used to decrease the length and severity of a relapse. 4. A stabilization of mood and sleep Incorrect - Some of the frequent side effects of a Methylprednisolone infusion are anxiety, insomnia, and mood swings.